Alteris Therapeutics, Inc.

Therapeutics and vaccines (CDX-110) against novel, proprietary cancer targets. Acquired by Celldex Therapeutics in 2005, which merged with Avant Immunotherapeutics in 2008.

Exited Portfolio Company

www.celldextherapeutics.com

Other Companies